GlaxoSmithKline said to eye sale of $3.9b stake in India's HUL

GlaxoSmithKline Plc (GSK) will soon begin selling its stake in Hindustan Unilever Ltd (HUL) estimated to be worth almost ₹29,850 crore ($3.9 billion), a person aware of the development said. GSK received the shares earlier this month in return for the sale of its Indian consumer business to HUL.